Selected Research References Seiwerth S, Sikiric P, Rucman R, et al
doi: 10.3389/fvets.2022.860771 Received 23 January 2022 Accepted 03 March 2022 Published 06 April 2022 Volume 9 - 2022 Edited by Valeria Pasciu, University of Sassari, Italy Reviewed by Ignacio Contreras Sols, University of Sassari, Italy
Phase 2 trial: up to 24.2% weight loss at 48 weeks
In this study, there was no apparent effect of creatinine clearance values on AUC and Cmax of NOVOLOG
While not a direct antibacterial agent, its regenerative properties make it an interesting subject for investigation into comprehensive skin health strategies
doi:10.1080/14740338.2018.1428305 230